Your browser doesn't support javascript.
loading
Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.
Darling, Alejandra; Tello, Cristina; Martí, María Josep; Garrido, Cristina; Aguilera-Albesa, Sergio; Tomás Vila, Miguel; Gastón, Itziar; Madruga, Marcos; González Gutiérrez, Luis; Ramos Lizana, Julio; Pujol, Montserrat; Gavilán Iglesias, Tania; Tustin, Kylee; Lin, Jean Pierre; Zorzi, Giovanna; Nardocci, Nardo; Martorell, Loreto; Lorenzo Sanz, Gustavo; Gutiérrez, Fuencisla; García, Pedro J; Vela, Lidia; Hernández Lahoz, Carlos; Ortigoza Escobar, Juan Darío; Martí Sánchez, Laura; Moreira, Fradique; Coelho, Miguel; Correia Guedes, Leonor; Castro Caldas, Ana; Ferreira, Joaquim; Pires, Paula; Costa, Cristina; Rego, Paulo; Magalhães, Marina; Stamelou, María; Cuadras Pallejà, Daniel; Rodríguez-Blazquez, Carmen; Martínez-Martín, Pablo; Lupo, Vincenzo; Stefanis, Leonidas; Pons, Roser; Espinós, Carmen; Temudo, Teresa; Pérez Dueñas, Belén.
Afiliação
  • Darling A; Unit of Pediatric Movement Disorders, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Tello C; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe, Valencia, Spain.
  • Martí MJ; Neurology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomediques IDIBAPS. Barcelona, Catalonia, Centro de Investigación Biomédica en Red-Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Garrido C; Pediatric Neurology Department, Centro Materno-Infantil Centro Hospitalario do Porto, Porto, Portugal.
  • Aguilera-Albesa S; Pediatric Neurology Department, Complejo Hospitalario de Navarra, Navarrabiomed, Pamplona, Spain.
  • Tomás Vila M; Pediatric Neurology Department, Hospital Universitario Politécnico La Fe, Valencia, Spain.
  • Gastón I; Neurology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Madruga M; Pediatric Neurology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • González Gutiérrez L; Pediatric Neurology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Ramos Lizana J; Pediatric Neurology Department, Hospital Torrecárdenas, Almería, Spain.
  • Pujol M; Neurology Department, Hospital Santa María, Lérida, Spain.
  • Gavilán Iglesias T; Neurology Department, Hospital de Mérida, Extremadura, Spain.
  • Tustin K; Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Lin JP; Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Zorzi G; Department of Pediatric Neuroscience, Fondazione IRCCS "C. Besta", Milano, Italy.
  • Nardocci N; Department of Pediatric Neuroscience, Fondazione IRCCS "C. Besta", Milano, Italy.
  • Martorell L; Molecular Genetics Department, Hospital Sant Joan de Déu, Barcelona. CIBERER, Instituto de Salud Carlos III, Madrid, Spain.
  • Lorenzo Sanz G; Pediatric Neurology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Gutiérrez F; Neurology Department, Complejo Asistencial Universitario de Palencia, Palencia, Spain.
  • García PJ; Neurology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • Vela L; Neurology Department, Hospital de Alcorcón, Madrid, Spain.
  • Hernández Lahoz C; Neurology Department, Hospital Central de Asturias, Oviedo, Spain.
  • Ortigoza Escobar JD; Unit of Pediatric Movement Disorders, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Martí Sánchez L; Unit of Pediatric Movement Disorders, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Moreira F; Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • Coelho M; Clinical Pharmacology Unit, Instituto de Medicina Molecular and Department of Neurosciences, Service of Neurology, Hospital Santa Maria, Lisboa, Portugal.
  • Correia Guedes L; Laboratory of Clinical Pharmacology and Therapeutics, Lisbon Faculty of Medicine, Lisbon, Portual.
  • Castro Caldas A; Neurology Department, Hospital de Santo Espirito, Ilha Terceira, Portugal.
  • Ferreira J; Clinical Pharmacology Unit, Instituto de Medicina Molecular and Department of Neurosciences, Service of Neurology, Hospital Santa Maria, Lisboa, Portugal.
  • Pires P; Laboratory of Clinical Pharmacology and Therapeutics, Lisbon Faculty of Medicine, Lisbon, Portual.
  • Costa C; Neurology Department, Hospital de Santo Espirito, Ilha Terceira, Portugal.
  • Rego P; Neurology Department, Hospital Fernando Fonseca, Lisboa, Portugal.
  • Magalhães M; Pediatric Department, Hospital Central de Funchal, Funchal, Portugal.
  • Stamelou M; Neurology Department, Centro Hospitalar Porto, Porto, Portugal.
  • Cuadras Pallejà D; Second Department of Neurology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Rodríguez-Blazquez C; Parkinson's Disease and other Movement Disorders Department, HYGEIA Hospital, Athens, Greece.
  • Martínez-Martín P; Statistical Department, Sant Joan de Déu Fundation, Barcelona, Spain.
  • Lupo V; National Center of Epidemiology and CIBERNED, Institute of Health Carlos III, Madrid, Spain.
  • Stefanis L; National Center of Epidemiology and CIBERNED, Institute of Health Carlos III, Madrid, Spain.
  • Pons R; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe, Valencia, Spain.
  • Espinós C; Second Department of Neurology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Temudo T; Pediatric Neurology Unit, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Hospital Agia Sofía, Athens, Greece.
  • Pérez Dueñas B; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Mov Disord ; 32(11): 1620-1630, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28845923
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Pessoas com Deficiência / Transtornos Parkinsonianos / Distonia / Neurodegeneração Associada a Pantotenato-Quinase Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Pessoas com Deficiência / Transtornos Parkinsonianos / Distonia / Neurodegeneração Associada a Pantotenato-Quinase Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha